FDX
36
-3
HBAN
59
3
EQR
39
-3
WEC
55
2
HBI
61
-4
AZO
50
5
TXN
46
14
MUR
30
-4
GIS
38
3
JNPR
59
-3
ADI
60
3
QRVO
51
15
WYNN
36
4
ESS
48
-2
NOV
63
5
OKE
73
2
LOW
52
3
APD
67
2
DHR
46
-4
HCA
50
4
FDX
36
-3
HBAN
59
3
EQR
39
-3
WEC
55
2
HBI
61
-4
AZO
50
5
TXN
46
14
MUR
30
-4
GIS
38
3
JNPR
59
-3
ADI
60
3
QRVO
51
15
WYNN
36
4
ESS
48
-2
NOV
63
5
OKE
73
2
LOW
52
3
APD
67
2
DHR
46
-4
HCA
50
4
Financhill
Back

Ocular Therapeutix 10K Form

Sell
34

OCUL
Ocular Therapeutix

Last Price:
$8.01
Seasonality Move:
23.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OCUL News And Ratings

See the #1 stock for the next 7 days that we like better than OCUL

OCUL Financial Statistics

Sales & Book Value

Annual Sales: $58.4M
Cash Flow: $-36.6M
Price / Cash Flow: 0
Annual Sales: $2.25
Price / Book: 3.58

Profitability

EPS (TTM): -1.32000
Net Income (TTM): $-174.3M
Gross Margin: $53.2M
Return on Equity: -70.49%
Return on Assets: -44.46%

Ocular Therapeutix Earnings Forecast

Key Ocular Therapeutix Financial Ratios

  • The Gross Profit Margin over the past 12 years for OCUL is 90.96%.
  • The Selling, General & Administrative Expenses for OCUL have been equal to 127.46% of Gross Profit Margin.
  • The Research & Development expenses have been 104.47% of Revenue.
  • The Net Earning history of OCUL is -138.14% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Ocular Therapeutix Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OCUL
CUSIP: 67576A
Website: ocutx.com

Debt

Debt-to-Equity Ratio: 0.19
Current Ratio: 13.01
Quick Ratio: 12.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OCUL Technical Analysis vs Fundamental Analysis

Sell
34
Ocular Therapeutix (OCUL) is a Sell

Is Ocular Therapeutix a Buy or a Sell?